Clinical Trial

BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation

Name: BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation — clinical trial record (NCT07246031)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase IIb open label study evaluates the safety and efficacy of repeat doses of BPC2001 in combination with standard of care treatment for the prevention of acute graft-vs-host-disease (aGvHD) in subjects following Haploidentical Stem Cell Transplantation (Haplo-SCT).

Trial Details

NCT Number	NCT07246031
Lead Sponsor	BioPhoenix Co., Ltd.
Conditions	Graft -Versus-host-disease, aGVHD, Haploidentical Stem Cell Transplantation, cGVHD
Enrollment	50 participants
Start Date	2025-10-29
Primary Completion	2027-11-02 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2025-11-24